Adapting Inhaled Medication Practice in COPD and Asthma to Avoid Funding the Tobacco Industry

The takeover of Vectura, a healthcare company specialising in inhaled medication, by Philip Morris International raises serious ethical concerns. The European Respiratory Society notes that “health professionals will avoid prescribing drugs from any company that enriches the tobacco industry due to...

Descripción completa

Detalles Bibliográficos
Autores principales: Capstick, Toby G D, Hopkinson, Nicholas S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554477/
https://www.ncbi.nlm.nih.gov/pubmed/34729008
http://dx.doi.org/10.2147/COPD.S337066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554477/
https://www.ncbi.nlm.nih.gov/pubmed/34729008
http://dx.doi.org/10.2147/COPD.S337066

Ejemplares similares